TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/25 18:15 | 1/24/25 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -10 | 0.4535 | 0 | -22 | -4 | 491 | D | ||||||||||||||
10/8/24 16:44 | 10/7/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -38 | 0.5662 | 0 | -68 | -13 | 452 | D | ||||||||||||||
9/11/24 16:01 | 9/9/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -2 | 0.6577 | 0 | -3 | -1 | 289 | D | ||||||||||||||
3/11/24 17:19 | 3/11/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -14 | 0.8820 | 0 | -15 | -5 | 292 | D | ||||||||||||||
2/12/24 17:23 | 2/12/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -4 | 1.01 | 0 | -4 | -1 | 307 | D | ||||||||||||||
11/3/23 16:40 | 11/1/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | S | -49 | 0.7300 | 0 | -68 | -18 | 311 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |